Clinical Trials Directory

Trials / Completed

CompletedNCT01757431

The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS)

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
2 (actual)
Sponsor
Alexion Pharmaceuticals, Inc. · Industry
Sex
All
Age
—
Healthy volunteers
Not accepted

Summary

Protocol is intended to characterize the overall safety and tolerability of eculizumab in this population.

Conditions

Interventions

TypeNameDescription
DRUGEculizumab

Timeline

Start date
2012-05-16
Primary completion
2013-09-24
Completion
2013-09-25
First posted
2012-12-31
Last updated
2017-03-10

Locations

2 sites across 1 country: Japan

Source: ClinicalTrials.gov record NCT01757431. Inclusion in this directory is not an endorsement.

The Safety and Efficacy of Eculizumab in Japanese Patients With Atypical Hemolytic Uremic Syndrome (aHUS) (NCT01757431) · Clinical Trials Directory